Full Text:   <3050>

CLC number: R453.9

On-line Access: 2012-08-01

Received: 2012-06-18

Revision Accepted: 2012-07-09

Crosschecked: 2012-07-18

Cited: 4

Clicked: 6238

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
1. Reference List
Open peer comments

Journal of Zhejiang University SCIENCE B 2012 Vol.13 No.8 P.638-644

http://doi.org/10.1631/jzus.B1201005


Renal insufficiency is an independent predictor of in-hospital mortality for patients with acute myocardial infarction receiving primary percutaneous coronary intervention


Author(s):  Jian-ping Li, Mohetaboer Momin, Yong Huo, Chun-yan Wang, Yan Zhang, Yan-jun Gong, Zhao-ping Liu, Xin-gang Wang, Bo Zheng

Affiliation(s):  Department of Cardiology, Peking University First Hospital, Peking University, Beijing 100043, China

Corresponding email(s):   muhtebar@hotmail.com, huoyong@263.net.cn

Key Words:  Acute myocardial infarction (AMI), Percutaneous coronary intervention (PCI), Renal function, Estimated glomerular filtration rate (eGFR), Mortality


Jian-ping Li, Mohetaboer Momin, Yong Huo, Chun-yan Wang, Yan Zhang, Yan-jun Gong, Zhao-ping Liu, Xin-gang Wang, Bo Zheng. Renal insufficiency is an independent predictor of in-hospital mortality for patients with acute myocardial infarction receiving primary percutaneous coronary intervention[J]. Journal of Zhejiang University Science B, 2012, 13(8): 638-644.

@article{title="Renal insufficiency is an independent predictor of in-hospital mortality for patients with acute myocardial infarction receiving primary percutaneous coronary intervention",
author="Jian-ping Li, Mohetaboer Momin, Yong Huo, Chun-yan Wang, Yan Zhang, Yan-jun Gong, Zhao-ping Liu, Xin-gang Wang, Bo Zheng",
journal="Journal of Zhejiang University Science B",
volume="13",
number="8",
pages="638-644",
year="2012",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1201005"
}

%0 Journal Article
%T Renal insufficiency is an independent predictor of in-hospital mortality for patients with acute myocardial infarction receiving primary percutaneous coronary intervention
%A Jian-ping Li
%A Mohetaboer Momin
%A Yong Huo
%A Chun-yan Wang
%A Yan Zhang
%A Yan-jun Gong
%A Zhao-ping Liu
%A Xin-gang Wang
%A Bo Zheng
%J Journal of Zhejiang University SCIENCE B
%V 13
%N 8
%P 638-644
%@ 1673-1581
%D 2012
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1201005

TY - JOUR
T1 - Renal insufficiency is an independent predictor of in-hospital mortality for patients with acute myocardial infarction receiving primary percutaneous coronary intervention
A1 - Jian-ping Li
A1 - Mohetaboer Momin
A1 - Yong Huo
A1 - Chun-yan Wang
A1 - Yan Zhang
A1 - Yan-jun Gong
A1 - Zhao-ping Liu
A1 - Xin-gang Wang
A1 - Bo Zheng
J0 - Journal of Zhejiang University Science B
VL - 13
IS - 8
SP - 638
EP - 644
%@ 1673-1581
Y1 - 2012
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1201005


Abstract: 
Objective: To investigate the relationship between renal function and clinical outcomes among patients with acute ST-segment elevation myocardial infarction (ASTEMI), who were treated with emergency percutaneous coronary intervention (PCI). Methods: 420 patients hospitalized in Peking University First Hospital, diagnosed with ASTEMI treated with emergency (PCI) from January 2001 to June 2011 were enrolled in this study. estimated glomerular filtration rate (eGFR) was used as a measure of renal function. We compared the clinical parameters and outcomes between ASTEMI patients combined renal insufficiency and the patients with normal renal function. Results: There was a significant increase in the concentrations of fibrinogen and D-Dimer (P<0.05) and a much higher morbidity of diabetes mellitus in the group of patients with chronic kidney disease (CKD; eGFR<60 ml/(min·1.73 m2)) (P<0.01). CKD (eGFR<60 ml/(min·1.73 m2)) was an independent predictor of in-hospital mortality for patients hospitalized with ASTEMI receiving PCI therapy rapidly (P=0.032, odds ratio (OR) 4.159, 95% confidence interval (CI) 1.127–15.346). Conclusions: Renal insufficiency is an independent predictor of in-hospital mortality for patients hospitalized with ASTEMI treated with primary PCI.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

[1]Anavekar, N.S., Mcmurray, J.J., Velazquez, E.J., Solomon, S.D., Kober, L., Rouleau, J.L., White, H.D., Nordlander, R., Maggioni, A., Dickstein, K., et al., 2004. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med., 351(13):1285-1295.

[2]Berrocal, D.H., Cohen, M.G., Spinetta, A.D., Ben, M.G., Rojas Matas, C.A., Gabay, J.M., Magni, J.M., Nogareda, G., Oberti, P., von Schulz, C., et al., 2003. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase. Am. Heart J., 146(6):E22.

[3]Chesebro, J.H., Knatterud, G., Roberts, R., Borer, J., Cohen, L.S., Dalen, J., Dodge, H.T., Francis, C.K., Hillis, D., Ludbrook, P., et al., 1987. Thrombolysis in myocardial infarction (TIMI) trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation, 76(1):142-154.

[4]Freeman, R.V., Mehta, R.H., Al Badr, W., Cooper, J.V., Kline-Rogers, E., Eagle, K.A., 2003. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J. Am. Coll. Cardiol., 41(5):718-724.

[5]Huo, Y., Ho, W., 2007. Renal status of ACS patients under going PCI study collaboration, renal insufficiency and clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a multi-centre study. J. Peking Univ. (Health Sci.), 39(6):624-629 (in Chinese).

[6]Kushner, F.G., Hand, M., Smith, S.C.Jr., King, S.B.3rd, Anderson, J.L., Antman, E.M., Bailey, S.R., Bates, E.R., Blankenship, J.C., Casey, D.E., et al., 2009. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol., 54(23):2205-2241.

[7]Levy, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N., Roth, D., 1999. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann. Intern. Med., 130(6):461-470.

[8]Levy, A.S., Greene, T., Kusek, J.W., Beck, G.J., Group, M.S., 2002. A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J. Am. Soc. Nephrol, 11:A0828.

[9]McCullough, P.A., 2002. Cardiorenal risk: an important clinical intersection. Rev. Cardiovasc. Med., 3(2):71-76.

[10]National Center for Cardiovascular Disease, 2008. 2006 Report on Cardiovascular Diseases in China. Publishing House of Encyclopedia of China, Beijing, China, p.1 (in Chinese).

[11]National Kidney Foundation, 2002. K/DOQ1 clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis., 39(2 Suppl. 1):S1-S266.

[12]Pitsavos, C., Kourlaba, G., Panagiotakos, D.B., Kogias, Y., Mantas, Y., Chrysohoou, C., Stefanadis, C., 2007. Association of creatinine clearance and in-hospital mortality in patients with acute coronary syndromes: the GREECS study. Circ. J., 71(1):9-14.

[13]Rabelink, T.J., Zwaginga, J.J., Koomans, H.A., Sixma, J.J., 1994. Thrombosis and hemostasis in renal disease. Kidney Int., 46(2):287-296.

[14]Schiele, F., Legalery, P., Didier, K., Meneveau, N., Seronde, M.F., Caulfield, F., Ducloux, D., Bechetoille, P., Magnin, D., Faivre, R., et al., 2006. Impact of renal dysfunction on 1-year mortality after acute myocardial infarction. Am. Heart J., 151(3):661-667.

[15]Shlipak, M.G., Heidenreich, P.A., Noguchi, H., Chertow, G.M., Browner, W.S., McClellan, M.B., 2002. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann. Intern. Med., 137(7):555-562.

[16]Shlipak, M.G., Fried, L.F., Crump, C., Bleyer, A.J., Manolio, T.A., Tracy, R.P., Furberg, C.D., Psaty, B.M., 2003. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation, 107(1):87-92.

[17]Sjøland, J.A., Sidelmann, J.J., Brabrand, M., Pedersen, R.S., Pedersen, J.H., Esbensen, K., Standeven, K.F., Ariens, R.A., Gram, J., 2007. Fibrin clot structure in patients with end-stage renal disease. Thromb. Haemost., 98(2):339-345.

[18]Szczech, L.A., Reddan, D.N., Owen, W.F., Califf, R., Racz, M., Jones, R.H., Hannan, E.L., 2001. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int., 60(1):292-299.

[19]Wannamethee, S.G., Shaper, A.G., Lowe, G.D., Lennon, L., Rumley, A., Whincup, P.H., 2006. Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers. Eur. Heart J., 27(24):2975-2981.

[20]Zachee, P., Vermylen, J., Boogaerts, M.A., 1994. Hematologic aspects of end-stage renal failure, Ann. Hematol., 69(1):33-40.

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE